NIPAH VIRUS: AN EMERGING INFECTIOUS DISEASE AND GLOBAL HEALTH CONCERN

Nipah contagion (NiV) is a largely pathogenic zoonotic contagion belonging to the Henipavirus rubric within the Paramyxoviridae family. It poses a significant public health double due to its high mortality rate (40–100), severe neurological and respiratory complications, and implicit for mortal-to-mortal transmission. First linked in Malaysia in 1998, NiV has ago caused intermittent outbreaks in South and Southeast Asia, particularly in Bangladesh and India Fruit batons of the Pteropus genus serve as the primary natural force, with transmission being through direct club contact, consumption of defiled food, or exposure to infected creatures. Mortal- to-mortal transmission has been well- proved, raising enterprises about epidemic eventuality. The pathogenesis of NiV involves severe endothelial damage, vacuities, encephalitis, and acute respiratory torture pattern (ARDS). Clinical instantiations range from mild flu- suchlike symptoms to fatal encephalitis and respiratory failure. opinion relies on RT- PCR, ELISA, and contagion insulation, though challenges live due to symptom imbrications with other conditions presently, there's no specific antiviral treatment or approved vaccine; patient operation is primarily probative, fastening on symptom relief, respiratory support, and ferocious care. Experimental curatives, including monoclonal antibodies (m 102.4), antiviral similar as remdesivir and ribavirin, and immunomodulators, are under disquisition. Due to adding spillover pitfalls from deforestation, climate change, and mortal- wildlife relations, NiV remains a precedence pathogen for global health surveillance. Continued exploration on vaccines, antiviral treatments, and effective outbreak control measures is pivotal to mollifying unborn pandemics.